Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127150822 | 12715082 | 2 | F | 2014 | 20160909 | 20160905 | 20160913 | EXP | JP-009507513-1508JPN010192 | MERCK | 53.00 | YR | F | Y | 0.00000 | 20160913 | CN | GB | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127150822 | 12715082 | 1 | PS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 100 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 17555 | 100 | MG | TABLET | QD | |||||
| 127150822 | 12715082 | 2 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 200-300 MG/DAY DAILY DOSE UNKNOWN | Y | 17555 | TABLET | QD | |||||||
| 127150822 | 12715082 | 3 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 600 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 17555 | 600 | MG | TABLET | QD | |||||
| 127150822 | 12715082 | 4 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | TAPERED, DAILY DOSAGE UNKNOWN | Y | 17555 | TABLET | QD | |||||||
| 127150822 | 12715082 | 5 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 50 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 17555 | 50 | MG | TABLET | QD | |||||
| 127150822 | 12715082 | 6 | SS | MENESIT TABLETS - 100 | CARBIDOPALEVODOPA | 1 | Oral | 100 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 17555 | 100 | MG | TABLET | QD | |||||
| 127150822 | 12715082 | 7 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 6 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 0 | 6 | MG | SUSTAINED RELEASE TABLET | QD | |||||
| 127150822 | 12715082 | 8 | SS | REQUIP | ROPINIROLE HYDROCHLORIDE | 1 | Oral | 1 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | Y | 0 | 1 | MG | SUSTAINED RELEASE TABLET | QD | |||||
| 127150822 | 12715082 | 9 | SS | ZYPREXA | OLANZAPINE | 1 | 5-10 MG | 0 | |||||||||||
| 127150822 | 12715082 | 10 | SS | ZYPREXA | OLANZAPINE | 1 | Unknown | 5 - 10 MG QD/DAILY DOSE UNKNOWN | 0 | QD | |||||||||
| 127150822 | 12715082 | 11 | SS | RISPERIDONE. | RISPERIDONE | 1 | Unknown | 2 MG, QD, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 2 | MG | QD | |||||||
| 127150822 | 12715082 | 12 | SS | QUETIAPINE FUMARATE. | QUETIAPINE FUMARATE | 1 | Oral | 75 MG, QD, FORMULATION: POR, DIVIDED DOSE FREQUENCY UNKNOWN | 0 | 75 | MG | QD | |||||||
| 127150822 | 12715082 | 13 | SS | LULLAN | PEROSPIRONE HYDROCHLORIDE | 1 | Oral | FORMULATION: POR, 8 - 16 MG/DAY, DAILY DOSE UNKNOWN | 0 | ||||||||||
| 127150822 | 12715082 | 14 | SS | NEUPRO | ROTIGOTINE | 1 | Transdermal | FORMULATION: PATCH, DAILY DOSAGE UNKNOWN | 0 | ||||||||||
| 127150822 | 12715082 | 15 | C | BIPERIDEN | BIPERIDEN | 1 | Oral | 6 MG, QD, FORMULATION: POR, DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | 6 | MG | QD | ||||||
| 127150822 | 12715082 | 16 | C | BIPERIDEN | BIPERIDEN | 1 | Oral | 3 MG, QD, FORMULATION: POR | U | 0 | 3 | MG | QD | ||||||
| 127150822 | 12715082 | 17 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1.5 MG, QD, FORMULATION: POR, DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | 1.5 | MG | QD | ||||||
| 127150822 | 12715082 | 18 | C | BROTIZOLAM | BROTIZOLAM | 1 | 0.25 MG QD, FORMULATION: POR, DIVIDED DOSE FREQUENCY UNKNOWN | U | 0 | .25 | MG | QD | |||||||
| 127150822 | 12715082 | 19 | C | YOKU-KAN-SAN | 2 | Oral | DAILY DOSAGE UNKNOWN | U | 0 | POWDER | |||||||||
| 127150822 | 12715082 | 20 | C | PEROSPIRONE | PEROSPIRONE | 1 | 8-16 MG | 0 | |||||||||||
| 127150822 | 12715082 | 21 | C | TIAPRIDE HYDROCHLORIDE | TIAPRIDE HYDROCHLORIDE | 1 | 50-150 MG, QD | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127150822 | 12715082 | 1 | Dementia with Lewy bodies |
| 127150822 | 12715082 | 7 | Parkinson's disease |
| 127150822 | 12715082 | 8 | Dementia with Lewy bodies |
| 127150822 | 12715082 | 13 | Restlessness |
| 127150822 | 12715082 | 15 | Parkinson's disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127150822 | 12715082 | HO |
| 127150822 | 12715082 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127150822 | 12715082 | Altered state of consciousness | |
| 127150822 | 12715082 | Condition aggravated | |
| 127150822 | 12715082 | Drug hypersensitivity | |
| 127150822 | 12715082 | Dyskinesia | |
| 127150822 | 12715082 | Oromandibular dystonia | |
| 127150822 | 12715082 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127150822 | 12715082 | 1 | 201309 | 2013 | 0 | |
| 127150822 | 12715082 | 2 | 201310 | 0 | ||
| 127150822 | 12715082 | 3 | 201405 | 201501 | 0 | |
| 127150822 | 12715082 | 4 | 201501 | 2015 | 0 | |
| 127150822 | 12715082 | 5 | 201502 | 2015 | 0 | |
| 127150822 | 12715082 | 6 | 201504 | 0 | ||
| 127150822 | 12715082 | 7 | 201501 | 0 | ||
| 127150822 | 12715082 | 8 | 201411 | 0 | ||
| 127150822 | 12715082 | 10 | 2013 | 0 | ||
| 127150822 | 12715082 | 14 | 2014 | 0 | ||
| 127150822 | 12715082 | 20 | 2013 | 0 | ||
| 127150822 | 12715082 | 21 | 2013 | 0 |